Amneal to Participate at Upcoming Investor Conferences

Rhea-AI Summary

Amneal Pharmaceuticals (Nasdaq: AMRX) has announced its participation in two major upcoming investor conferences. Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will represent the company.

The first event is the 36th Annual Piper Sandler Healthcare Conference in New York on December 4, 2024, featuring a fireside chat at 11:00 AM EST. The second is the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco from January 13-15, 2025, with a presentation scheduled for January 15 at 10:30 AM PST.

Both events will be accessible via live webcast on Amneal's investor relations website, with replays available afterward.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in two upcoming investor conferences.

36^th Annual Piper Sandler Annual Healthcare Conference
December 4, 2024
Fireside chat – 11:00 AM EST
New York, NY

43^rd Annual J.P. Morgan Healthcare Conference
January 13 – 15, 2025
Presentation – January 15 at 10:30 AM PST
San Francisco, CA

A live webcast will be accessible on the Company's website at https://investors.amneal.com. A replay of the webcast will be available following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 generic and specialty pharmaceuticals, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com and follow us on LinkedIn.

Cautionary Statement on Forward-Looking Statements

Certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). Such forward-looking statements include statements regarding management’s intentions, plans, beliefs, expectations, financial results, or forecasts for the future, including among other things: discussions of future operations; expected or estimated operating results and financial performance; and statements regarding our positioning, including our ability to drive sustainable long-term growth, and other non-historical statements. Words such as “plans,” “expects,” “will,” “anticipates,” “estimates,” and similar words, or the negatives thereof, are intended to identify estimates and forward-looking statements. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company’s filings with the Securities and Exchange Commission, including under Item 1A, “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and in its subsequent reports on Forms 10-Q and 8-K. Forward-looking statements included herein speak only as of the date hereof and we undertake no obligation to revise or update such statements to reflect the occurrence of events or circumstances after the date hereof.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241204578625/en/

Amneal Contact

Anthony DiMeo

VP, Investor Relations

anthony.dimeo@amneal.com

Source: Amneal Pharmaceuticals, Inc.

FAQ

When is Amneal (AMRX) presenting at the Piper Sandler Healthcare Conference 2024?

Amneal will participate in a fireside chat at the Piper Sandler Healthcare Conference on December 4, 2024, at 11:00 AM EST in New York.

What time is Amneal's (AMRX) presentation at the 2025 J.P. Morgan Healthcare Conference?

Amneal will present at the J.P. Morgan Healthcare Conference on January 15, 2025, at 10:30 AM PST in San Francisco.

How can I watch Amneal's (AMRX) investor conference presentations?

Live webcasts of Amneal's presentations will be available on the company's investor relations website at https://investors.amneal.com, with replays available after the events.

Which Amneal (AMRX) executives are participating in the upcoming investor conferences?

Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the conferences.